Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families
1999

Breast cancer risk in ataxia telangiectasia heterozygotes

publication Evidence: moderate

Author Information

Author(s): Janin N, Andrieu N, Ossian K, Laugé A, Croquette M-F, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D

Primary Institution: Institut Gustave Roussy

Hypothesis

Do ataxia telangiectasia heterozygotes have an increased risk of breast cancer?

Conclusion

The study found a significant increase in breast cancer risk among obligate ATM heterozygotes.

Supporting Evidence

  • The relative risk of breast cancer was assessed using French estimated incidence rates.
  • A significant increase risk of breast cancer was found among obligate ATM heterozygotes with a point estimate of 3.32.
  • Breast cancer relative risk is significantly increased among obligate ATM heterozygotes female relatives aged 44 years or younger.

Takeaway

People who carry a specific genetic change related to ataxia telangiectasia may have a higher chance of getting breast cancer.

Methodology

Family data was collected, including demographic characteristics and cancer occurrences, and DNA samples were analyzed using microsatellite markers.

Limitations

The increased risk is only slightly higher than classical reproductive risk factors.

Participant Demographics

French families with ataxia telangiectasia.

Statistical Information

P-Value

0.002

Statistical Significance

p=0.002

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690460

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication